GDPR Considerations for DtP Supply Chains
Regulatory, Supply Chain
One of the primary challenges with Direct-to-Patient (DtP) supply chains is maintaining patient privacy. This is further complicated by the GDPR (General Data Protection Regulation), which is broadly designed to protect the right to personal data privacy for all EU citizens. The GCSG DTP Sub-team provides an overview of the key GDPR considerations and recommendations for organizations engaged in DtP.
Related Education Resources.
All Resources2023 US Conference - Sponsorship and Exhibitor Overview
Topic: Conference
Video
Free
Lessons Learned: Conducting COVID Clinical Trials and Building a Clinical Supplies Team During the Peak of the Pandemic
Topics: Conference, COVID-19
Executive Summary
Members
Brexit & the future landscape for clinical trial supplies in the UK and Europe
Topics: Pharma Industry, Regulatory, Supply Chain
Position Paper
Free